Clinician’s Digest piece for the January/February issue of Psychotherapy Networker:
At a time when public attitudes toward the medical use of marijuana are rapidly changing, it’s probably not surprising that the therapeutic use of MDMA—better known by its street name, ecstasy—is receiving renewed attention. But rather than recalling Harvard psychologists Timothy Leary and Richard Alpert’s Psilocybin Project in the 1960s, today’s investigators are undertaking government-sanctioned research using the traditional methods of systematic observation and careful measurement. Leading the way is the Multidisciplinary Association for Psychedelic Studies (MAPS), an independent nonprofit that’s raised millions of dollars to fund research on the use of MDMA to treat war veterans and other trauma survivors.
Read more here.